The roles of nitric oxide and prostaglandins in alterations of ulcerogenic and healing responses in adjuvant-induced arthritic rat stomachs

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 14, Issue 1, 2000, Pages 18-25

  Kato, S ^a   Tanaka, A ^a   Kunikata, T ^a   Mizoguchi, H ^a   Takeuchi, K ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; ALCOHOL; ARGININE METHYL ESTER; FREUND ADJUVANT; GRANULOCYTE ANTIBODY; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH ULCER; ULCER HEALING; ULCEROGENESIS;

EID: 0034109040     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.014s1018.x     Document Type: Conference Paper

References (26)

1. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 1971; 231: 232-5.
2. Whittle BJR. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981; 80: 94-8.
3. Fries JF, Miller SR, Spitz PW, et al. Toward an epidemiology of gastropathy associated with non-steroidal antiinflammatory drug use. Gastroenterology 1989; 96: 647-55.
4. Schleyerbach R, Wedde H. Alternation in the gastro-intestinal functions during the development of adjuvant disease in rats. Agents Actions 1984; 15: 392-7.
5. DiPasquale G, Welaj P. Ulcerogenic potential of indomethacin in arthritic and non-arthritic rats. J Pharm Pharmac 1973; 25: 831-2.
6. McCafferty D-M, Granger DN, Wallace JL. Indomethacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rats. Gastroenterology 1995; 109: 1173-80.
7. Kato S, Tanaka A, Kunikata T, Nishijima M, Takeuchi K. Changes in gastric mucosal ulcerogenic responses in rats with adjuvant arthritis: role of nitric oxide. Alim Pharmacol Ther 1999; 13: 833-40.
8. Inatomi N, Ishihara Y, Okabe S. Effects of anti-ulcer agents on thermal-cortisone-induced ulcers in rats. Jpn J Pharmacol 1979; 29: 486-8.
9. Brown JF, Tepperman BL, Hanson PJ, Whittle BJ, Moncada S. Differential distribution of nitric oxide synthase between cell fractions isolated from the rat gastric mucosa. Biochem Biophys Res Commun 1992; 184: 680-5.
10. Futaki N, Hamasaka Y, Arai I, Higuchi S, Otomo S. A new test for evaluating nonsteroidal anti-inflammatory drugs in vitro; inhibition of prostaglandin E2 production in minced intestinal tissue. Arch Int Pharmacodyn Ther 1992; 316: 114-23.
11. Rainsford KD. The role of aspirin in gastric ulceration; some factors involved in the development of gastric mucosal damage induced by aspirin in rats exposed to various stress conditions. Dig Dis 1978; 23: 521-30.
12. Lopez-Belmonte J, Whittle BJR, Moncada S. The action of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol 1993; 108: 73-8.
13. Ribbons RA, Zhang XJ, Thompson JH, et al. Potential role of nitric oxide in a model of chronic colitis in rhesus macaques. Gastroenterology 1995; 108: 705-11.
14. Mourelle M, Vllaseca J, Guarner P, et al. Toxic dilation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase. Am J Physiol 1996; 270: G425-30.
15. Yasuhiro T, Ukawa H, Kato S, Takeuchi K. Involvement of nitric oxide (NO) and inducible NO synthase in the pathogenesis of inflammatory gastric lesions induced by compound 48/80 in rats. J Physiol (Paris) 1997; 91: 151-8.
16. Yasuhiro T, Korolkiewicz RP, Kato S, Takeuchi K. Role of nitric oxide in pathogenesis of serotonin-induced gastric lesions in rats. Pharmacol Res 1997; 36: 335-8.
17. Whittle BJR, Laszlo F, Evans SM, Moncada S. Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br J Pharmacol 1995; 116: 2286-90.
18. Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol 1990; 259: G462-7.
19. Wallace JL, Arfors KE, McKnight GW. A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit. Gastroenterology 1991; 100: 878-83.
20. Wallace JL, McKnight W, Miyasaka M, et al. Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. Am J Physiol 1993; 265: G993-8.
21. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4.
22. Santucci L, Fiorucci S, Giansanti M, Brunori PM, Di Matteo FM, Morelli A. Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. Gut 1994; 35: 909-15.
23. Appleyard CB, McCafferty DM, Tigley AW, Swain MG, Wallace JL. Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am J Physiol 1996; 270: G42-8.
24. Yamamoto N, Sakai F, Yamazaki H, Nakahara K, Okuhara M. Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation. Eur J Pharmacol 1996; 314: 137-42.
25. Tepperman BL, Soper BD. Nitric oxide synthase induction and cytoprotection of rat gastric mucosa from injury by ethanol. Can J Physiol Pharmacol 1994; 72: 1308-12.
26. Wang JY, Yamasaki S, Takeuchi K, Okabe S. Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin. Gastroenterology 1989; 96: 393-402.